arrow
S

Susan M. Domchek

penn ovarian cancer research center
H指数:104
被引数:4.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blood-based RNA biomarker for the early detection of ovarian cancer

基于血液的RNA生物标志物用于卵巢癌的早期检测

2026-11-100
PRE
Saturation mutagenesis enables RAD51D clinical variant interpretation and identifies distinct biochemical functions

饱和诱变有助于RAD51D临床变异的解释并识别不同的生化功能

2026-10-030
OA
A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocol

随机化混合型I有效性-实施研究:一种用于遗传性癌症的癌症基因检测eHealth交付替代方案(eREACH2)研究方案

2026-07-310
OAAI
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 Variants

向携带致病性BRCA1/2变异的女性披露乳腺癌多基因风险评分对风险降低性乳房切除术决策冲突的影响

2026-05-210
OAAI
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)

在影响开始的地方进行投资:乳腺癌研究基金会早期职业研究员工作组建议(第一部分,共两部分)

2026-05-010
PRE
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification

结合变异效应的多重检测方法以增强BRCA2变异分类

2026-04-090
OAAI
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

乳腺癌的同源重组缺陷和半合子驱动抵抗

Nature
IF48.5
2026-03-040
OAAI
Sexual Function, Activity and Distress 24 Months After Surgical Menopause: What Happens After Menopause (WHAM)—A Prospective Controlled Study

性功能、活动度和痛苦:术后绝经24个月后的变化——绝经后会发生什么(WHAM)——一项前瞻性对照研究

2026-01-220
OA
An electronic review of clinical outcomes after return of actionable genetic research results from a health system research biobank

基于健康系统研究生物库可操作遗传研究结果返回后的临床结局电子回顾研究

2025-11-010
OAAI
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes

BRCA1-、BRCA2-和PALB2相关的范可尼贫血:扩展疾病表型特征并预测杂合子乳腺癌风险的潜力

2025-10-300
PRE
The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing

MyCancerGene研究:一项混合型I类效果-实施随机研究,比较在接收癌症基因检测后,患者为中心的数字遗传健康门户与常规护理的效果。

2025-10-260
OAAI
What Happens After Menopause (WHAM)? A Progress Report of a Prospective Controlled Study of Women After Pre-Menopausal Risk-Reducing Bilateral Salpingo-Oophorectomy

绝经后会发生什么(WHAM)?一项关于绝经前风险降低性双侧输卵管卵巢切除术后的女性进行的前瞻性对照研究的进展报告

2025-07-230
OAAI
Comprehensive RAD51C ovarian cancer variant analysis uncouples homologous recombination and replicative functions

综合RAD51C卵巢癌变异分析解耦同源重组和复制功能

2025-07-160
OA
Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventions
2024-10-010
OAAI
Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk

开发整合单基因,多基因和流行病学风险的乳腺癌风险预测模型

2024-09-110
PRE